Ophthalmic Drugs Market 2025 to 2034
Ophthalmic Drugs Market 2025 to 2034
Medical Display Market (By Device: Desktop, Mobile, All in one; By Panel Size: Up to 22.9, 23.0 to 26.9, 27.0 to 41.9, Above 42; By Resolution: Up to 2Mp, 2.1 to 4Mp, 4.1 to 8Mp, Above 8Mp; By Application: Multi-Modality, Digital Pathology, Radiology, Surgical, Mammography) - Global Industry Analysis, SiOphthalmic Drugs Market (By Disease: Eye Allergy, Eye Infection, Glaucoma, Retinal Disorders, Dry Eye, Others; By Drug Class: Anti-Allergy, Anti-Inflammatory, Antiglaucoma, Anti-VEGF Agents; By Dosage: Eye Solutions, Gels, Capsules, Eye Drops, Ointments; By Administration: Systematic, Topical, Local Ocular; By Product: Prescription Drugs, Over-the-Counter-Drugs) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034ze, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034
Customisation Request
Revenue, 2025
USD 45.35 Bn
Forecast Year, 2034
USD 72.38 Bn
CAGR, 2025 - 2034
5.30%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global ophthalmic drugs market, valued at USD 45.35 billion in 2025, is poised to reach USD 72.38 billion by 2034, expanding at a CAGR of 5.3%, driven by rising eye disorders, aging populations, and advancements in drug therapies.
Ophthalmic Drugs Market Size Analysis
Ophthalmic Drugs Market Size By Disease 2025 to 2034 (USD Billion)
| Disease | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Eye Allergy | 16.66 | 17.34 | 17.50 | 17.99 | 18.20 | 18.72 | 19.00 | 19.06 | 19.82 | 20.76 |
| Eye Infection | 1.38 | 1.91 | 2.60 | 2.63 | 3.39 | 4.12 | 4.50 | 5.22 | 5.62 | 6.79 |
| Glaucoma | 7.42 | 7.47 | 7.53 | 8.20 | 8.68 | 9.51 | 10.54 | 11.01 | 11.62 | 11.87 |
| Retinal Disorders | 9.03 | 9.08 | 9.60 | 10.22 | 11.14 | 11.63 | 12.05 | 12.52 | 13.31 | 14.00 |
| Dry Eye | 1.48 | 2.15 | 2.53 | 3.10 | 3.30 | 3.44 | 4.05 | 4.69 | 5.00 | 5.21 |
| Others | 9.28 | 9.90 | 10.53 | 10.81 | 11.05 | 11.29 | 11.69 | 12.60 | 13.18 | 13.55 |
Ophthalmic Drugs Market Size By Drug Class 2025 to 2034 (USD Billion)
| Drug Class | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Allergy | 22.83 | 24.00 | 24.89 | 25.65 | 26.56 | 27.26 | 28.29 | 29.12 | 29.90 | 30.59 |
| Anti-Inflammatory | 1.18 | 1.47 | 1.59 | 2.17 | 3.09 | 3.74 | 4.48 | 5.68 | 6.64 | 7.50 |
| Antiglaucoma | 1.58 | 2.11 | 2.95 | 3.96 | 4.32 | 4.94 | 5.74 | 6.34 | 6.87 | 8.27 |
| Anti-VEGF Agents | 19.76 | 20.17 | 20.86 | 21.17 | 21.78 | 22.78 | 23.31 | 23.95 | 25.13 | 25.82 |
Ophthalmic Drugs Market Size By Dosage 2025 to 2034 (USD Billion)
| Dosage | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Eye Solutions | 2.94 | 3.26 | 4.10 | 4.57 | 5.12 | 6.03 | 6.24 | 7.51 | 7.61 | 8.04 |
| Gels | 12.18 | 12.83 | 13.37 | 13.89 | 14.95 | 15.66 | 16.70 | 17.37 | 18.01 | 19.07 |
| Capsules | 6.03 | 6.50 | 6.73 | 7.63 | 8.25 | 8.34 | 8.48 | 8.91 | 9.97 | 11.27 |
| Eye Drops | 4.87 | 5.61 | 6.02 | 6.07 | 6.29 | 6.61 | 7.65 | 7.80 | 8.25 | 8.67 |
| Ointments | 19.32 | 19.56 | 20.06 | 20.79 | 21.15 | 22.06 | 22.76 | 23.51 | 24.71 | 25.13 |
Ophthalmic Drugs Market Size By Administration 2025 to 2034 (USD Billion)
| Administration | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Systematic | 6.44 | 7.07 | 7.32 | 8.19 | 9.12 | 10.18 | 10.78 | 11.76 | 12.29 | 12.95 |
| Topical | 4.35 | 5.29 | 6.25 | 7.04 | 7.46 | 8.15 | 9.16 | 10.11 | 11.04 | 12.25 |
| Local Ocular | 34.56 | 35.40 | 36.72 | 37.71 | 39.18 | 40.38 | 41.88 | 43.23 | 45.22 | 46.99 |
Ophthalmic Drugs Market Size By Product 2025 to 2034 (USD Billion)
| Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Prescription Drugs | 1.32 | 1.62 | 1.78 | 2.30 | 2.65 | 3.64 | 4.39 | 4.65 | 5.86 | 6.40 |
| Over-the-Counter-Drugs | 44.03 | 46.13 | 48.51 | 50.65 | 53.11 | 55.07 | 57.43 | 60.45 | 62.69 | 65.79 |
Ophthalmic Drugs Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 7.52 | 7.90 | 8.86 | 9.56 | 10.21 | 10.34 | 11.24 | 12.31 | 13.18 | 13.88 |
| Europe | 6.16 | 6.86 | 7.00 | 7.64 | 8.59 | 9.02 | 9.12 | 9.55 | 9.80 | 10.80 |
| Asia-Pacific | 11.69 | 11.72 | 12.25 | 12.89 | 12.92 | 13.67 | 14.23 | 15.13 | 15.96 | 16.98 |
| Latin America | 2.52 | 3.14 | 3.21 | 3.50 | 3.87 | 4.46 | 5.38 | 6.36 | 7.11 | 8.15 |
| MEA | 17.46 | 18.13 | 18.96 | 19.35 | 20.17 | 21.22 | 21.84 | 21.75 | 22.38 | 22.50 |
Ophthalmic Drugs Market Size to Reach USD 72.38 Billion by 2034
The global ophthalmic drugs market size was estimated at USD 45.35 billion in 2025 and is projected to be worth around USD 72.38 billion by 2034,with a CAGR of 5.30%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
